Cargando…
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
The immune-cell origin of hematologic malignancies provides a unique avenue for the understanding of both the mechanisms of immune responsiveness and immune escape, which has accelerated the progress of immunotherapy. Several categories of immunotherapies have been developed and are being further ev...
Autores principales: | Tang, Lu, Huang, Zhongpei, Mei, Heng, Hu, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435569/ https://www.ncbi.nlm.nih.gov/pubmed/37591844 http://dx.doi.org/10.1038/s41392-023-01521-5 |
Ejemplares similares
-
T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
por: Tang, Lu, et al.
Publicado: (2021) -
Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017) -
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
por: Xu, Zhengli, et al.
Publicado: (2021) -
Therapeutic Advances in Immunotherapies for Hematological Malignancies
por: Nogami, Ayako, et al.
Publicado: (2022) -
Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
por: Lamb, Margaret G., et al.
Publicado: (2021)